Skip to content

Clinical trials

Phase 2 Hepatitis C trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 2 Country / region: Canada Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20062
20072
20095
20106
20115
20121
20154
20161
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Withdrawn3
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb6
Gilead Sciences4
BioWest Therapeutics Inc3
Vertex Pharmaceuticals Incorporated3
Human Genome Sciences Inc.2
Tibotec Pharmaceuticals, Ireland2
AbbVie (prior sponsor, Abbott)1
Atea Pharmaceuticals, Inc.1
Boehringer Ingelheim1
Carelon Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C31
Hepatitis C, Chronic9
Liver Cirrhosis3
Hepatitis2
Bronchiolitis Obliterans Syndrome1
Chronic Pain1
Coinfection1
Fibrosis1
HIV Infections1
Infections1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.